APA (7th ed.) Citation

Sunkaraneni S, Passarell JA, Ludwig EA, Fiedler-Kelly J, Pitner JK, Grinnell TA, & Blum D. (2017). Prediction of efficacy for conversion from adjunctive therapy to monotherapy with eslicarbazepine acetate 800 mg once daily for partial-onset epilepsy. Dove Medical Press.

Chicago Style (17th ed.) Citation

Sunkaraneni S, Passarell JA, Ludwig EA, Fiedler-Kelly J, Pitner JK, Grinnell TA, and Blum D. Prediction of Efficacy for Conversion from Adjunctive Therapy to Monotherapy with Eslicarbazepine Acetate 800 Mg Once Daily for Partial-onset Epilepsy. Dove Medical Press, 2017.

MLA (9th ed.) Citation

Sunkaraneni S, et al. Prediction of Efficacy for Conversion from Adjunctive Therapy to Monotherapy with Eslicarbazepine Acetate 800 Mg Once Daily for Partial-onset Epilepsy. Dove Medical Press, 2017.